Literature DB >> 12821744

Clinical aspects of MuSK antibody positive seronegative MG.

D B Sanders1, K El-Salem, J M Massey, J McConville, A Vincent.   

Abstract

Serum antibodies to muscle-specific receptor tyrosine kinase were detected in 12 of 32 patients with generalized seronegative MG. All were women, with onset between ages 21 and 59 years. Seven had prominent neck, shoulder, or respiratory muscle weakness and little or delayed ocular muscle involvement. The response to cholinesterase inhibitors was variable, and electromyographic findings suggested myopathy in several. None improved after thymectomy. All patients improved after plasma exchange, and most had a good response to selected immunotherapy. MuSK antibody status should help diagnose MG with atypical presentations and ensure appropriate patient treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821744     DOI: 10.1212/01.wnl.0000065882.63904.53

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  81 in total

Review 1.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.

Authors:  Maria I Leite; Margaret Jones; Philipp Ströbel; Alexander Marx; Ralf Gold; Erik Niks; Jan J G M Verschuuren; Sonia Berrih-Aknin; Francesco Scaravilli; Aurea Canelhas; B Paul Morgan; Angela Vincent; Nick Willcox
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

3.  Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Authors:  Y Nemoto; S Kuwabara; S Misawa; N Kawaguchi; T Hattori; M Takamori; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

4.  MuSK-antibody positive pure ocular myasthenia gravis.

Authors:  Frank Hanisch; Katharina Eger; Stephan Zierz
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

5.  Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.

Authors:  Jane W Chan; William W Orrison
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

6.  Anti-MuSK antibodies in a case of ocular myasthenia gravis.

Authors:  D L H Bennett; K R Mills; P Riordan-Eva; P R J Barnes; M R Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

7.  Myasthenia gravis: Five new things.

Authors:  Jeffrey M Statland; Emma Ciafaloni
Journal:  Neurol Clin Pract       Date:  2013-04

Review 8.  Effectiveness of thymectomy in non-thymomatous myasthenia gravis: a systematic review.

Authors:  Yan Luo; Deng-Ji Pan; Fei-Fei Chen; Ming-Hui Zhu; Jing Wang; Min Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

9.  Animal models of antimuscle-specific kinase myasthenia.

Authors:  David P Richman; Kayoko Nishi; Michael J Ferns; Joachim Schnier; Peter Pytel; Ricardo A Maselli; Mark A Agius
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

Review 10.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.